Skip to content

LFCR - LIFECORE BIOMEDICAL, INC. DE - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchL

Lifecore Biomedical Inc.

LFCR · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

L

LFCRLifecore Biomedical Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $8.98
52-wk low: $3.63
Prev close: $7.05
Mkt cap: $168.8M
Fwd P/E: 8.7x
Beta: 1.09

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$17.7M

MW
Marshall Wace
Q2 2026 13F
$932K
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 5, 2026

Earnings came in 11.8% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -23.8%
Forward P/E: 8.67
Market cap: $169M

Valuation

P/S1.30
P/B197.99

Quality

Operating margin7.5%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: LFCR
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $168.82M
Beta: 1.09

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

1.3x

P/B

198.0x

Profit margin

-23.8%

Op margin

+7.5%

ROE

-76.4%

$700K

position

JS

Jim Simons

Q2 2026 13F

$551K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for LFCR

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.19-11.8%

-$0.17 expected

Next report

What the street expects next

-76.4%

ROA-3.0%

Growth

Beta1.09